Close
ACHEMA MIDDLE EAST 2026

J&J partners HHS to speed-up coronavirus vaccine development

Johnson & Johnson (J&J) unit Janssen Pharmaceutical has partnered with the US Department of Health & Human Services (HHS) to speed-up the development of...

Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

The transaction is expected to be completed in the third quarter of Catalent’s 2020 financial year, and is subject to customary closing conditions. Following...

Applied BioMath, LLC Announces Collaboration with Gritstone Oncology, Inc

Applied BioMath , the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, announced a collaboration...

Avacta and Daewoong Agree Collaboration and License Agreement with AffyXell Therapeutics

Avacta Group plc , the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has signed a collaboration and license agreement...

WPD Pharmaceuticals Completed the Acquisition of Two Drug Candidates

WPD PharmaceuticalsInc. ,a clinical stage pharmaceutical company, provides this update on the completed acquisition of exclusive sublicenses for two drug candidates from Moleculin Biotech,...

Genome & Company announces a clinical trial collaboration and supply agreement with Merck KGaA

Genome & Company is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany...

Bridge Biotherapeutics Announces FDA IND Clearance for BBT-176, an EGFR TKI for NSCLC

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced that the Investigational New Drug (IND) application submitted to...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...